Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Brentuximab Vedotin (SGN-35) in CD30-Positive Systemic Mastocytosis With or Without an Associated Hematological Clonal Non-Mast Cell Lineage Disease (AHNMD)

NCT01807598 is registered in ClinicalTrials.gov with Jason Robert Gotlib as lead sponsor.

NCT NCT01807598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01807598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Brentuximab Vedotin (SGN-35) in CD30-Positive Systemic Mastocytosis With or Without an Associated Hematological Clonal Non-Mast Cell Lineage Disease (AHNMD)
Lead sponsor
Jason Robert Gotlib
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
September 30, 2017
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aggressive systemic mastocytosis, mast cell leukemia, systemic mastocytosis